Thomas Jefferson University Concussions Nuclear Imaging SPECT

January 29, 2014 — Researchers are seeking to understand what happens inside the living brain after a concussion.  In a study published today in PLOS ONE, researchers at Thomas Jefferson University used single photon emission computed tomography (S.P.E.C.T.) to evaluate two ways to measure physiological brain activity in Traumatic Brain Injury (T.B.I.) patients with chronic, mild symptoms. The findings of their blinded, case-control study are published in an article entitled, Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury. The study included 25 cases and 10 controls.
 
The researchers used S.P.E.C.T. to track cerebral blood flow (C.B.F.), movement of blood through the brain and neurotransmitter dopamine by tracking the binding of a dopamine transporter (D.A.T.) tracer.
 
T.B.I. patients were discovered to have an average of six brain regions with abnormal perfusion, while controls had an average of two abnormal regions (P<0.0001).  Patients with headaches had lower C.B.F. in the right frontal lobe and higher C.B.F. in the left parietal lobe compared to patients without headaches. Lower C.B.F. in the right temporal lobe correlated with poorer reported physical health. Higher D.A.T. binding was associated with more depressive symptoms and overall poorer reported mental health.  However, there was no clear association between C.B.F. and D.A.T. binding in the patients studied.
 
Researchers concluded that S.P.E.C.T. imaging of D.A.T. and C.B.F. were useful tools that provide distinct information about brain physiology after T.B.I.
 
For more information: www.jefferson.edu

Related Content

News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Sept. 26, 2025 — A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently ...

Time October 03, 2025
arrow
News | Radiopharmaceuticals and Tracers

Sept. 20, 2025 — A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative ...

Time September 18, 2025
arrow
News | Nuclear Imaging

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...

Time May 06, 2025
arrow
News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | ASTRO

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
Subscribe Now